Maynard Um
-
-
-
-
-
-
-
Wells Fargo Downgrades aTyr Pharma (ATYR) to Equal Weight
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
-
-
-
-
-
-
-
aTyr Pharma (ATYR) to be Added to the Russell 2000® and Russell 3000 Indexes
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
-
-
-
-
-
-
-
aTyr Pharma (ATYR) Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT Study
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on aTyr Pharma (ATYR)
-
-
-
-
-
-
-
Here's the list of biotech stocks that have key data catalysts in 2025
-
404,920 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

